5,582 Shares in HealthEquity, Inc. (NASDAQ:HQY) Acquired by FORA Capital LLC

FORA Capital LLC bought a new stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 5,582 shares of the company's stock, valued at approximately $536,000.

Other large investors have also added to or reduced their stakes in the company. Ameritas Investment Partners Inc. grew its position in HealthEquity by 0.3% during the 4th quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company's stock worth $3,248,000 after purchasing an additional 88 shares during the period. Smartleaf Asset Management LLC boosted its stake in shares of HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after buying an additional 98 shares during the last quarter. Louisiana State Employees Retirement System grew its holdings in HealthEquity by 0.4% during the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock worth $2,322,000 after acquiring an additional 100 shares during the period. Oregon Public Employees Retirement Fund raised its position in HealthEquity by 0.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company's stock valued at $1,706,000 after acquiring an additional 100 shares in the last quarter. Finally, State of Michigan Retirement System lifted its holdings in HealthEquity by 0.5% in the fourth quarter. State of Michigan Retirement System now owns 20,722 shares of the company's stock valued at $1,988,000 after acquiring an additional 100 shares during the period. 99.55% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on HQY shares. Barrington Research reaffirmed an "outperform" rating and set a $112.00 target price on shares of HealthEquity in a report on Friday, April 11th. Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and decreased their price objective for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. Wells Fargo & Company increased their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th. The Goldman Sachs Group cut their price target on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research note on Thursday, March 27th. Finally, KeyCorp reduced their price target on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. One investment analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, HealthEquity presently has an average rating of "Buy" and a consensus target price of $111.75.

Insiders Place Their Bets

In related news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the transaction, the director now directly owns 84,969 shares in the company, valued at $6,597,842.85. This trade represents a 6.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Michael Henry Fiore sold 8,881 shares of HealthEquity stock in a transaction dated Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the transaction, the executive vice president now directly owns 56,655 shares of the company's stock, valued at $4,433,820.30. This trade represents a 13.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.

HealthEquity Stock Up 0.3%

Shares of HQY traded up $0.33 during mid-day trading on Tuesday, reaching $96.99. 1,537,007 shares of the stock traded hands, compared to its average volume of 791,498. The firm has a market cap of $8.39 billion, a price-to-earnings ratio of 88.98, a P/E/G ratio of 1.60 and a beta of 0.45. The stock has a fifty day simple moving average of $87.82 and a 200 day simple moving average of $96.81. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.